More participants on semaglutide than on placebo achieved both MASH resolution and liver fibrosis reductions (32.8% vs 16.2%), meeting a secondary trial goal
Triggering of eryptosis, the suicidal erythrocyte death by mammalian target of rapamycin (mTOR) inhibitor temsirolimus
VP11 Bridging Technology and Trust: Leveraging AI and Health Behavior Theory to Combat Misinformation in African American Communities Akorfa Adobor 1 , Tyson Le 2 , Tatenda Makoni 1 , Philisha Mesidor 1 1 MCW, Milwaukee, Wisconsin, USA, 2 MCW, Wauwatosa, Wisconsin, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :VP11 Aims African-American communities are disproportionately affected by health misinformation
The court order requires that third-party organizations, including pharmacies, healthcare providers, insurers, and military medical institutions, produce documents that may assist in verifying usage
This data illustrates the shifting dynamics within the GLP-1 market and underscores the importance of innovation and clinical outcomes in shaping market leadership
